407 related articles for article (PubMed ID: 30203578)
1. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
2. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats.
Stenzig J; Schneeberger Y; Löser A; Peters BS; Schaefer A; Zhao RR; Ng SL; Höppner G; Geertz B; Hirt MN; Tan W; Wong E; Reichenspurner H; Foo RS; Eschenhagen T
J Mol Cell Cardiol; 2018 Jul; 120():53-63. PubMed ID: 29792884
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
[TBL] [Abstract][Full Text] [Related]
6. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
[TBL] [Abstract][Full Text] [Related]
7. Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.
Yamamoto M; Cid E; Bru S; Yamamoto F
PLoS One; 2011 Mar; 6(3):e17149. PubMed ID: 21423795
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
[TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
12. Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
Wu M; Sun Q; Mo CH; Pang JS; Hou JY; Pang LL; Lu HP; Dang YW; Fang SJ; Tang D; Chen G; Feng ZB
Oncol Rep; 2019 Jul; 42(1):151-175. PubMed ID: 31059074
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation biomarkers for head and neck squamous cell carcinoma.
Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H
Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis.
Zhang W; Wang H; Qi Y; Li S; Geng C
Sci Rep; 2022 Feb; 12(1):1989. PubMed ID: 35132081
[TBL] [Abstract][Full Text] [Related]
16. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
Tao C; Luo R; Song J; Zhang W; Ran L
J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
[TBL] [Abstract][Full Text] [Related]
17. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
18. Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
Fernandez-Jimenez N; Sklias A; Ecsedi S; Cahais V; Degli-Esposti D; Jay A; Ancey PB; Woo HD; Hernandez-Vargas H; Herceg Z
Epigenetics; 2017; 12(11):964-972. PubMed ID: 29099283
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
